- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02742298
Pompe Disease QMUS and EIM
September 24, 2020 updated by: Duke University
Electrical Impedance Myography and Muscle Ultrasound: Longitudinal Measures in Pompe Disease
Study Objectives:
- Determine the correlation between quantitative muscle ultrasound (QMUS), electrical impedance myography (EIM) and currently accepted measures of physical function.
- Determine the reliability of EIM measures performed in the home through use of a hand held device.
- Determine if QMUS and EIM can detect pre-clinical changes in Pompe disease.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Genetically confirmed diagnosis of Pompe disease.
Exclusion Criteria:
- Age <18 years
- Inability to provide informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: QMUS
All patients will undergo serial quantitative muscle ultrasound.
|
Ultrasound images of limb muscles will be collected.
|
|
Other: EIM
All patients will undergo serial electrical impedance myography measures.
|
A painless current passes through the skin and surface electrodes are used to record the impedance through muscle.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Percent change in muscle ultrasound echointensity as compared to baseline
Time Frame: Baseline, 1-2 years
|
Baseline, 1-2 years
|
|
Percent change in muscle electrical impedance myography as compared to baseline
Time Frame: Baseline, 1-2 years
|
Baseline, 1-2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Inter-rater reliability of muscle ultrasound and electrical impedance myography measures
Time Frame: 1-2 years
|
1-2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Lisa D Hobson-Webb, MD, Duke University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 24, 2016
Primary Completion (Actual)
July 31, 2020
Study Completion (Actual)
July 31, 2020
Study Registration Dates
First Submitted
April 11, 2016
First Submitted That Met QC Criteria
April 13, 2016
First Posted (Estimate)
April 19, 2016
Study Record Updates
Last Update Posted (Actual)
September 25, 2020
Last Update Submitted That Met QC Criteria
September 24, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Metabolic Diseases
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Genetic Diseases, Inborn
- Carbohydrate Metabolism, Inborn Errors
- Metabolism, Inborn Errors
- Lysosomal Storage Diseases
- Brain Diseases, Metabolic
- Brain Diseases, Metabolic, Inborn
- Lysosomal Storage Diseases, Nervous System
- Glycogen Storage Disease
- Glycogen Storage Disease Type II
Other Study ID Numbers
- Pro00072199
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pompe Disease
-
University of Erlangen-Nürnberg Medical SchoolCompletedPompe Disease (Late-onset) | Pompe Disease | Pompe's Disease Juvenile Onset | Pompe Disease Infantile-OnsetGermany
-
Centre for Analytical Biochemistry and Biomedical...University of GiessenRecruiting
-
GeneCradle IncRecruitingPompe Disease (Late-onset)China
-
Seventh Medical Center of PLA General HospitalGeneCradle Therapeutics, IncRecruiting
-
Aro BiotherapeuticsCompletedHealthy | Late Onset Pompe DiseaseCanada, United States
-
GeneCradle IncActive, not recruitingPompe Disease Infantile-OnsetChina
-
Fundació Institut de Recerca de l'Hospital de la...Genzyme, a Sanofi CompanyUnknownPompe Disease | Late Onset Pompe DiseaseSpain
-
Amicus TherapeuticsTerminatedLate-onset Pompe DiseaseUnited States, Canada, Australia, Belgium
-
Duke UniversityCompleted
-
BioMarin PharmaceuticalTerminatedLate-onset Pompe DiseaseUnited States, United Kingdom, Germany, France, Italy, Portugal, Belgium, Netherlands
Clinical Trials on Muscle ultrasound
-
Groupe Hospitalier Paris Saint JosephHopital ForcillesActive, not recruitingCOVID-19 | Weaning Failure | ICU Acquired WeaknessFrance
-
Wake Forest University Health SciencesCompletedCritical Illness | Acute Respiratory FailureUnited States
-
Assiut UniversityNot yet recruitingLimb-girdle Muscular Dystrophy
-
Sichuan Provincial People's HospitalNot yet recruitingSarcopenia | Kidney Transplantation | Muscle WastingChina
-
Tan Tock Seng HospitalCompleted
-
Eman Alaa Eldean MohamedNot yet recruiting
-
Hopital ForcillesCompleted
-
Pedro AbizandaPuerta de Hierro University Hospital; Hospital Universitario Infanta Leonor; Hospital... and other collaboratorsCompleted
-
University Hospital, ToulouseNot yet recruitingFrailty | Intensive Care Unit Syndrome
-
Hospital Israelita Albert EinsteinRecruitingSARS-CoV-2 Acute Respiratory DiseaseBrazil